Skip to content
value.today
Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH
$500 Mmarket cap on Oct 20, 2026+449.3% since Jan 2024
Compare
World rank
#12,561
Revenue
$85 M
For year ending December-2025
Net income
$3 M
3.2% margin
SEC filing
Employees
156
As of February 13, 2026
SEC filing

Delcath Systems, Inc. in brief

Delcath Systems, Inc. is a listed company in the Medical Devices industry, based in Delaware, USA. Its market value was $500 M on 20 October 2026, which makes it the 12,561st largest listed company in the world and the 2,536th largest in the USA on this site. In the year to December 2025 it had sales of $85 M and a net profit of $3 M, about 3 cents of profit for every dollar of sales. It employs about 156 people and Gerard J. Michel is its chief executive. Its largest product and service lines by sales in 2025 were HEPZATO KIT (92%) and CHEMOSAT (8%). By market, the largest shares of its 2025 sales came from USA (92%). Its shares trade under the symbol DCTH (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Delcath Systems, Inc.

We are an interventional oncology company focused on the treatment of cancers primary or metastatic to the liver. Our lead product, the HEPZATOTM KIT (melphalan for Injection/Hepatic Delivery System), a drug/device combination product, was approved by the US Food and Drug Administration on August 14, 2023, indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection, or radiation. The first commercial use of the HEPZATO for the treatment of metastatic hepatic dominant uveal melanoma took place in January 2024.

From the company's annual report filed with the US SEC: read the report

Delcath Systems, Inc. timeline

2 events, 2000–2025
  1. 2000
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2025
  4. 💰
    Record revenue of $85 million
    FY2025, the highest of the 5 years on record.

Events of Delcath Systems, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$157 M$314 M$471 M$627 M2023202420252026

World rank over time

▲ up 13,827 places since 2022
2022-01-07: #26424#26,42420222022-12-25: #26766#26,76620222023-07-30: #25693#25,69320232024-01-05: #21910#21,91020242026-03-08: #8251#8,25120262026-08-01: #11653#11,65320262026-10-14: #12367#12,36720262026-10-20: #12597#12,5972026

Rank in USA: #4,863 (Jan 2022) · #4,992 (Dec 2022) · #4,796 (Jul 2023) · #3,760 (Jan 2024) · #1,500 (Mar 2026) · #2,440 (Aug 2026) · #2,485 (Oct 2026) · #2,539 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
75.2×
Price / sales (TTM)
4.5×
Price / book
4.5×
Free cash flow yield
4.2%
Net margin (TTM)
6.0%
Operating margin
0.8%
Return on equity
6.0%
Liabilities / assets
10.0%
Net debt
$-32M
Revenue growth
+129.1%
R&D / revenue
34.3%
Revenue per employee
$546 K
Profit per employee
$17 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-19M—FY18Fiscal year ending Dec 2019: revenue —, net income $-9M—FY19Fiscal year ending Dec 2020: revenue —, net income $-24M—FY20Fiscal year ending Dec 2021: revenue $4M, net income $-26M$4MFY21Fiscal year ending Dec 2022: revenue $3M, net income $-37M$3MFY22Fiscal year ending Dec 2023: revenue $2M, net income $-48M$2MFY23Fiscal year ending Dec 2024: revenue $37M, net income $-26M$37MFY24Fiscal year ending Dec 2025: revenue $85M, net income $3M$85MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$85M+129.1%$1M$3M3.2%
Dec 2024$37M+1705.8%$-12M$-26M-70.9%
Dec 2023$2M-24.3%$-38M$-48M-2314.6%
Dec 2022$3M-23.6%$-34M$-37M-1342.3%
Dec 2021$4M—$-25M$-26M-720.5%
Dec 2020——$-21M$-24M—
Dec 2019——$-20M$-9M—
Dec 2018——$-27M$-19M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$23M$2M$21M$0.07—
Dec 2024$-19M$1M$-19M$-0.93—
Dec 2023$-31M$0M$-31M$-2.94—
Dec 2022$-25M$0M$-25M$-4.12—
Dec 2021$-23M$0M$-23M$-3.59—
Dec 2020$-23M$1M$-24M$-8.35—
Dec 2019$-24M$0M$-24M$-342.83—
Dec 2018$-15M$0M$-15M$-0.72—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$110M
Net income, trailing 12 months
$7M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $15M, net income $-3M$15MDec ’24Three months to Mar 2025: revenue $20M, net income $1M$20MMar ’25Three months to Jun 2025: revenue $24M, net income $3M$24MJun ’25Three months to Sep 2025: revenue $21M, net income $1M$21MSep ’25Three months to Dec 2025 (from the annual report): revenue $21M, net income $-2M$21MDec ’25Three months to Mar 2026: revenue $25M, net income $-1M$25MMar ’26Three months to Jun 2026: revenue $29M, net income $3M$29MJun ’26Three months to Sep 2026: revenue $35M, net income $7M$35MSep ’26

Latest quarter to Sep 2026: revenue $35M (+70.7% on a year earlier), net income $7M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Delcath Systems, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$85 M
Operating income
$1 M
Net income
$3 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$124 M
Total liabilities
$12 M
Total equity
$111 M

As of December-2025

Top 100 institutional investors in Delcath Systems, Inc.#

As of Sep 30, 2026
145 institutions held 20.7 M shares (about 59.6% of the shares outstanding) on Sep 30, 2026. The ten largest hold 38.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Delcath Systems, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.3,996,569+1,289,767 (+47.65%)11.49%$64 MNov 13, 2026
2Rosalind Advisors, Inc.3,300,3890 (0.00%)9.49%$53 MNov 16, 2026
3Vanguard Capital Management LLC1,229,641+8,394 (+0.69%)3.53%$20 MNov 13, 2026
4ExodusPoint Capital Management, LP862,710+502,826 (+139.72%)2.48%$14 MNov 16, 2026
5Geode Capital Management, LLC822,901+89,786 (+12.25%)2.37%$13 MNov 6, 2026
6Algert Global LLC773,999+193,291 (+33.29%)2.22%$12 MNov 17, 2026
7State Street Corp759,942+80,662 (+11.87%)2.18%$12 MNov 12, 2026
8Millennium Management LLC608,023+41,652 (+7.35%)1.75%$10 MNov 16, 2026
9Propel Bio Management, LLC604,664-266,796 (-30.61%)1.74%$10 MNov 13, 2026
10Morgan Stanley550,557+142,574 (+34.95%)1.58%$9 MNov 13, 2026
11Marshall Wace, LLP371,893+152,930 (+69.84%)1.07%$6 MNov 13, 2026
12Goldman Sachs Group Inc368,763+118,451 (+47.32%)1.06%$6 MNov 16, 2026
13Arrowstreet Capital, Limited Partnership356,926New1.03%$6 MNov 13, 2026
14Vanguard Portfolio Management LLC335,171+141,723 (+73.26%)0.96%$5 MNov 13, 2026
15Dimensional Fund Advisors LP314,903+104,605 (+49.74%)0.91%$5 MNov 4, 2026
16Private Wealth Advisors, LLC289,028-21,835 (-7.02%)0.83%$5 MNov 16, 2026
17Northern Trust Corp248,821-3,287 (-1.30%)0.72%$4 MNov 16, 2026
18Simplify Asset Management Inc.227,679-37,091 (-14.01%)0.65%$4 MOct 27, 2026
19ADAR1 Capital Management, LLC224,3850 (0.00%)0.65%$4 MNov 16, 2026
20Kennedy Capital Management LLC197,978-6,165 (-3.02%)0.57%$3 MNov 13, 2026
21Vanguard Fiduciary Trust Co192,857+10,954 (+6.02%)0.55%$3 MNov 13, 2026
22AQR Capital Management LLC190,051+17,058 (+9.86%)0.55%$3 MNov 16, 2026
23Nuveen, LLC170,335-11,260 (-6.20%)0.49%$3 MNov 10, 2026
24Tudor Investment Corp Et Al168,318+156,276 (+1297.76%)0.48%$3 MNov 16, 2026
25Jpmorgan Chase & Co150,424+137,486 (+1062.65%)0.43%$2 MNov 12, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Delcath Systems, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Barclays PLC147,166+39,216 (+36.33%)0.42%$2 MNov 6, 2026
27Lane Generational LLC143,971-5,692 (-3.80%)0.41%$2 MNov 9, 2026
28HSBC Holdings PLC143,474+7,874 (+5.81%)0.41%$2 MNov 16, 2026
29Ikarian Capital, LLC135,667-50,000 (-26.93%)0.39%$2 MNov 16, 2026
30Gsa Capital Partners LLP128,151+42,201 (+49.10%)0.37%$2 MNov 16, 2026
31Man Group plc120,622-7,873 (-6.13%)0.35%$2 MNov 16, 2026
32Acadian Asset Management LLC114,009New0.33%$2 MNov 9, 2026
33Bank of New York Mellon Corp112,013+3,854 (+3.56%)0.32%$2 MNov 5, 2026
34CIBC World Market Inc.111,982-51,226 (-31.39%)0.32%$2 MNov 10, 2026
35Ameriprise Financial Inc95,094New0.27%$2 MNov 16, 2026
36Jump Financial, LLC93,589+5,554 (+6.31%)0.27%$1 MNov 13, 2026
37Russell Investments Group, Ltd.88,727+21,069 (+31.14%)0.26%$1 MNov 6, 2026
38Jefferies Financial Group Inc.83,9800 (0.00%)0.24%$1 MNov 5, 2026
39Charles Schwab Investment Management Inc83,519+54 (+0.06%)0.24%$1 MNov 16, 2026
40Capital Advisors Wealth Management, LLC83,500-9,500 (-10.22%)0.24%$1 MOct 9, 2026
41Bank Of America Corp /de/79,621+18,097 (+29.41%)0.23%$1 MNov 16, 2026
42Citadel Advisors LLC69,178+54,135 (+359.87%)0.20%$1 MNov 16, 2026
43Franklin Templeton Inc64,906New0.19%$1 MNov 12, 2026
44SEI Investments Co63,378+32,009 (+102.04%)0.18%$1 MNov 10, 2026
45Point72 Asset Management, L.P.61,977New0.18%$1 MNov 16, 2026
46BNP Paribas Financial Markets61,271+3,617 (+6.27%)0.18%$1 MNov 12, 2026
47Strs Ohio59,000New0.17%$1 MOct 30, 2026
48UBS Group AG54,479+12,765 (+30.60%)0.16%$1 MNov 10, 2026
49Boothbay Fund Management, LLC52,885+27,509 (+108.41%)0.15%$1 MNov 16, 2026
50Informed Momentum Co LLC52,359New0.15%$1 MNov 16, 2026
51Creative Planning52,208+3,774 (+7.79%)0.15%$1 MNov 2, 2026
52Aquatic Capital Management LLC49,745New0.14%$1 MNov 16, 2026
53Alps Advisors Inc45,640+10,600 (+30.25%)0.13%$1 MNov 3, 2026
54D. E. Shaw & Co., Inc.45,023-12,871 (-22.23%)0.13%$1 MNov 16, 2026
55Rhumbline Advisers44,800+8,356 (+22.93%)0.13%$1 MNov 10, 2026
56American Century Companies Inc44,521+14,467 (+48.14%)0.13%$1 MNov 12, 2026
57Quantbot Technologies LP40,420-19,140 (-32.14%)0.12%$1 MNov 12, 2026
58Occudo Quantitative Strategies LP39,067New0.11%$1 MNov 16, 2026
59Palisades Investment Partners, LLC37,818+14,545 (+62.50%)0.11%$1 MNov 3, 2026
60Citigroup Inc35,088+21,793 (+163.92%)0.10%$1 MNov 4, 2026
61Quadrature Capital Ltd34,994New0.10%$1 MNov 13, 2026
62XTX Topco Ltd29,969New0.09%$0 MNov 16, 2026
63Kopp Family Office, LLC28,189New0.08%$0 MOct 21, 2026
64Alliancebernstein L.P.25,8000 (0.00%)0.07%$0 MNov 16, 2026
65State of Alaska, Department of Revenue25,669-364 (-1.40%)0.07%$0 MOct 15, 2026
66Campbell & CO Investment Adviser LLC25,666New0.07%$0 MNov 13, 2026
67Deutsche Bank AG\25,532-3,704 (-12.67%)0.07%$0 MNov 6, 2026
68Xcelsior Advisor Partners LLC25,3000 (0.00%)0.07%$0 MNov 13, 2026
69Price T Rowe Associates Inc /MD/23,796+2,317 (+10.79%)0.07%$0 MNov 16, 2026
70Los Angeles Capital Management LLC22,395New0.06%$0 MNov 12, 2026
71Susquehanna International Group, LLP21,426New0.06%$0 MNov 16, 2026
72Trexquant Investment LP21,109New0.06%$0 MNov 16, 2026
73Entropy Technologies, LP20,553New0.06%$0 MNov 13, 2026
74Bailard, Inc.20,006New0.06%$0 MOct 13, 2026
75WINTON GROUP Ltd18,900New0.05%$0 MNov 12, 2026
76MetLife Investment Management, LLC18,6690 (0.00%)0.05%$0 MNov 16, 2026
77Engineers Gate Manager LP17,550New0.05%$0 MNov 16, 2026
78WealthPlan Investment Management, LLC17,4430 (0.00%)0.05%$0 MOct 15, 2026
79Cornerstone Investment Partners, LLC17,170New0.05%$0 MNov 16, 2026
80Invesco Ltd.16,910-877 (-4.93%)0.05%$0 MNov 12, 2026
81Employees Retirement System of Texas16,489New0.05%$0 MNov 10, 2026
82Royal Bank Of Canada15,881+1,602 (+11.22%)0.05%$0 MNov 16, 2026
83Public Employees Retirement System Of Ohio14,165New0.04%$0 MNov 16, 2026
84MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.13,956+713 (+5.38%)0.04%$0 MNov 16, 2026
85LPL Financial LLC12,072+1,837 (+17.95%)0.03%$0 MNov 6, 2026
86Mercer Global Advisors Inc /adv11,591+412 (+3.69%)0.03%$0 MNov 16, 2026
87Mariner, LLC11,244New0.03%$0 MNov 12, 2026
88Lanark Financial, Inc.11,000-954 (-7.98%)0.03%$0 MOct 26, 2026
89New York State Common Retirement Fund10,900+6,100 (+127.08%)0.03%$0 MNov 17, 2026
90Vanguard Global Advisers, LLC10,775+142 (+1.34%)0.03%$0 MNov 13, 2026
91Two Sigma Investments, LP10,700+646 (+6.43%)0.03%$0 MNov 16, 2026
92EntryPoint Capital, LLC10,662-24,099 (-69.33%)0.03%$0 MNov 13, 2026
93Nomura Holdings Inc10,093-6,629 (-39.64%)0.03%$0 MNov 16, 2026
94Leonteq Securities AG10,000-17,699 (-63.90%)0.03%$0 MOct 29, 2026
95Wells Fargo & Company/mn9,305-19,047 (-67.18%)0.03%$0 MNov 16, 2026
96Police & Firemen's Retirement System of New Jersey8,7950 (0.00%)0.03%$0 MNov 9, 2026
97Osaic Holdings, Inc.5,829+1,043 (+21.79%)0.02%$0 MNov 12, 2026
98FMR LLC5,568+71 (+1.29%)0.02%$0 MNov 10, 2026
99Arax Advisory Partners3,581-540 (-13.10%)0.01%$0 MNov 12, 2026
100UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3,170+2,816 (+795.48%)0.01%$0 MNov 16, 2026

All 145 institutional investors, with who bought and sold →

Mutual funds holding Delcath Systems, Inc.#

99 funds hold shares worth $56 M (about 9.7% of the company). Since their previous reports 44 added shares and 29 sold, buying $7 M net.
Mutual funds holding Delcath Systems, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.889,410$11 M1.9%<0.01%−9.5%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors757,196$10 M1.6%0.01%+3.3%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC314,275$4 M0.66%0.01%+5.5%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.304,809$4 M0.64%<0.01%−2.6%Jun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors229,809$3 M0.48%0.02%newJun 30, 2026
🇺🇸 North Square Dynamic Small Cap FundNorth Square Investments, LLC192,363$2 M0.40%0.26%+184%May 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC141,229$2 M0.30%<0.01%+282%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.154,942$2 M0.33%<0.01%+5.4%May 31, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC122,700$2 M0.26%0.15%newJun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC140,170$2 M0.29%<0.01%−1.2%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors96,698$1 M0.20%0.08%+27%Jun 30, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC100,899$1 M0.21%0.02%newMay 29, 2026
🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds73,405$1 M0.15%0.11%newJun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.70,457$1 M0.15%0.01%+7.3%Jul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP70,373$1 M0.15%<0.01%+266%Jul 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP69,314$1 M0.15%0.01%+605%Jul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC52,189$1 M0.11%0.01%no changeJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC51,878$1 M0.11%<0.01%no changeMay 31, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors43,402$1 M0.09%<0.01%+2.6%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors39,522$0 M0.08%<0.01%−84%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC39,123$0 M0.08%0.01%no changeJul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC41,083$0 M0.09%<0.01%+1.9%May 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC34,175$0 M0.07%0.02%newJun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP34,591$0 M0.07%<0.01%+385%Jul 31, 2026
🇺🇸 ALPS Medical Breakthroughs ETFALPS Advisors, Inc.35,814$0 M0.08%0.24%+14%May 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.35,321$0 M0.07%0.04%−17%May 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC28,655$0 M0.06%<0.01%no changeJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC27,330$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.28,071$0 M0.06%0.02%+3.1%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation20,600$0 M0.04%0.01%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust22,609$0 M0.05%<0.01%+250%May 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC20,799$0 M0.04%<0.01%no changeMay 31, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors17,467$0 M0.04%<0.01%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.15,583$0 M0.03%<0.01%−12%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.14,954$0 M0.03%0.01%−2.2%Jun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC14,284$0 M0.03%<0.01%+8.3%Jul 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC13,736$0 M0.03%0.01%+5.0%Jul 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.12,977$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP12,489$0 M0.03%<0.01%newJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.11,445$0 M0.02%<0.01%−27%Jun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC11,270$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC11,200$0 M0.02%<0.01%+111%Jun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC11,200$0 M0.02%<0.01%+111%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.11,100$0 M0.02%<0.01%+16%Jun 30, 2026
🇺🇸 WisdomTree U.S. SmallCap FundWisdomTree Asset Management, Inc.10,622$0 M0.02%0.02%−2.3%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.9,780$0 M0.02%<0.01%+54%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company11,215$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC9,593$0 M0.02%<0.01%−1.6%Jul 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC9,118$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC8,023$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC6,454$0 M0.01%0.04%+17%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC6,127$0 M0.01%0.01%+8.6%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC5,880$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS5,681$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC5,277$0 M0.01%0.05%newJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC4,778$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.4,273$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC4,237$0 M<0.01%0.01%+21%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.4,182$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC3,993$0 M<0.01%<0.01%−83%Jun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION4,500$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC3,959$0 M<0.01%0.01%−2.6%Jul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC3,808$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC3,721$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.3,689$0 M<0.01%<0.01%−4.5%Jul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC3,440$0 M<0.01%0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP3,297$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management3,075$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC2,866$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC2,627$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS2,652$0 M<0.01%0.01%no changeJul 31, 2026
🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP2,307$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC2,231$0 M<0.01%0.01%−11%Jun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC2,147$0 M<0.01%0.01%+14%Jun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.2,475$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC2,023$0 M<0.01%0.02%newJun 30, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC1,956$0 M<0.01%<0.01%+16%Jun 30, 2026
🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC1,718$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC1,638$0 M<0.01%<0.01%−4.9%May 31, 2026
🇺🇸 SA U.S. Small Company FundFocus Advisor Solutions, LLC1,306$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC1,288$0 M<0.01%<0.01%−35%Jun 30, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC1,420$0 M<0.01%<0.01%+10%May 31, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS1,179$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC1,132$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC1,302$0 M<0.01%<0.01%newMay 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC1,073$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC1,122$0 M<0.01%<0.01%−39%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC1,111$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC909$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC756$0 M<0.01%<0.01%−82%Jun 30, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.741$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC693$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC575$0 M<0.01%<0.01%−6.2%Jun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC428$0 M<0.01%<0.01%−81%Jun 30, 2026
🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC367$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC324$0 M<0.01%<0.01%−84%Jul 31, 2026
🇺🇸 Vanguard Growth And Income FundWellington Management Company LLP300$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC161$0 M<0.01%<0.01%−4.2%Jul 31, 2026
🇺🇸 State Street Balanced Index FundSSGA Funds Management, Inc.136$0 M<0.01%<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 99 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Delcath Systems, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$189 K
3 purchases, 3 insiders
Sold, 12 months
$489 K
2 sales, 1 insider
Net, 12 months
-$299 K
open market only
Insiders on file
32
since
$561 K-$489 K$0Nov 2023: bought $561 K (4 trades), sold $0 (0 trades)Nov 23Dec 2023: bought $220 K (2 trades), sold $0 (0 trades)DecMar 2024: bought $100 K (2 trades), sold $0 (0 trades)MarNov 2025: bought $137 K (2 trades), sold $0 (0 trades)NovMar 2026: bought $150 K (2 trades), sold $0 (0 trades)MarNov 2026: bought $0 (0 trades), sold $489 K (2 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals
Delcath Systems, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Bridget A. MartellDirectorOption exercise+22,500$7.850$177 K22,500Form 4
filed Bridget A. MartellDirectorSell-20,570$21.66$446 K1,930Form 4
filed Bridget A. MartellDirectorSell-1,930$22.26$43 K0Form 4
filed Rosalind Advisors, Inc.DirectorConversionindirect+3,627——3.42 MForm 4
filed Rosalind Advisors, Inc.DirectorOtherindirect-27,502——3.39 MForm 4
filed Sandra PennellChief Financial OfficerBuy+5,533$9.040$50 K77,018Form 4
filed Gerard J. MichelCHIEF EXECUTIVE OFFICER, DirectorBuy+11,200$8.960$100 K342,034Form 4
filed John Richard SylvesterDirectorBuy+4,386$8.890$39 K14,936Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Delcath Systems, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
1.8 M
5.1% of shares · 5.74 days to cover
Buybacks, Q3 2026
$0M
Q3 2026
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-704.23 reverse split ; 1-for-500 reverse split ; 1-for-344.83 reverse split ; 1-for-16 reverse split ; 1-for-16 reverse split in the period to

Delcath Systems, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q3 2026$0M
Q2 2026Q2 2026$0M
Q1 2026Q1 2026$3M
Q4 2025Q4 2025$6M
Q3 2025Q3 2026$0M
Q2 2025Q2 2026$0M
Q1 2025Q1 2026$0M
Q1 2012Q1 2012$0M
Q4 2011Q4 2011$0M
Q3 2011Q3 2011$0M
Q2 2011Q2 2011$0M
Q1 2011Q1 2012$0M
Q4 2010Q4 2011$0M
Q3 2010Q3 2011$0M

Fails to deliver

  • : 232 shares at $14.37
  • : 197 shares at $15.32
  • : 650 shares at $16.40
  • : 2,350 shares at $16.11
  • : 696 shares at $15.80

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Delcath Systems, Inc. scorecard#

Passes 11 of the 21 checks that could be worked out: strongest in growth (5 of 5), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 20, 2026.

  • Valuation0 of 5
    • ✗P/E below its peers' median75.2×P/E 75.2× against Medical Devices's median of 24.1×.
    • ✗Price to book below its peers' median4.5×Price to book 4.5× against Medical Devices's median of 2.5×.
    • ✗Price to sales below its peers' median4.5×Price to sales 4.5× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%4.2%Free cash flow is 4.2% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield1.3%Earnings yield 1.3% against the 10-year Treasury's 5.15% on 2026-11-13.
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth5 of 5
    • ✓Revenue grew in the newest year129.1%Revenue up 129.1% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years215.3%215.3% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median215.3%215.3% a year against Medical Devices's median of 10.8% (73 companies).
    • ✓Earnings per share grew in the newest year0.07 vs -0.93Diluted EPS 0.07 in fiscal 2025 against -0.93 the year before (report's currency).
    • ✓Net income higher than five years earlier$3 M$3 M in fiscal 2025 against -$24 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability3 of 5
    • ✓Profitable in the newest year$3 MNet income $3 M in fiscal 2025.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median0.8%0.8% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%3.0%3.0% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier0.8%0.8% in fiscal 2025 against -1244.5% in 2022.
  • Financial health2 of 3
    • ✓Short-term assets cover short-term liabilities10.9×Current ratio 10.92 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone19.94Z-score 19.94 (safe zone) for fiscal 2025.
  • Shareholder returns1 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year40.0%Diluted shares up 40.0% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value1.2%Dividends and buybacks were 1.2% of the market value.
    • ✓Free cash flow covers dividends and buybacks$21 MFree cash flow $21 M against $6 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Delcath Systems, Inc.'s statements, beside the median of Medical Devices.

Delcath Systems, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin0.8%-8.2%
Net margin3.2%-10.4%
Return on equity3.0%-16.8%
Revenue growth, 3 years a year215.3%10.8%
Revenue growth129.1%10.4%
Free cash flow margin24.6%-1.9%

6of 8on the Piotroski tests of financial strength

  • The share count rose 40.0% in the year.

Delcath Systems, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Delcath Systems, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue85372.12.73.6———2.72.0
Cost of revenue126.20.60.70.70.60.71.00.70.6
Gross profit73311.42.02.91.00.92.42.01.4
Research and development2914181914119.520108.4
Selling, general and administrative443022171411119.89.79.4
Operating expenses73434036272221292018
Operating income0.7−12−38−34−25−21−20−27−18−16
Interest and finance income—————————0.0
Interest expense and finance costs————————2214
Other non-operating income (expense)−0.1−0.0−0.10.00.10.20.00.1−0.00.0r
Income before tax3.5−26−48−37−26−24−8.9−19−45−18
Income tax0.8000000000
Net income including minority interests————−26−24—−19−45—
Minority interests' share of net income—————248.9———
Net income attributable to shareholders2.7−26−48−37−26−24−8.9−19−45−18
Earnings per share, basic0.08-0.93-2.94-4.12-3.59-8.35-342.83r-0.72-3,250.00r-3,707.00r
Earnings per share, diluted0.07-0.93-2.94-4.12-3.59-8.35-342.83r-0.72-3,250.00r-3,707.00r
Shares, weighted average (basic)3629168.97.12.90.0270.0—
Shares, weighted average (diluted)4029168.97.12.90.0270.0r0.0r
Balance sheet
Cash and cash equivalents4332137.72329102.54.04.4
Short-term investments4821200——————
Receivables12110.20.40.00.10.00.60.30.4
Inventory106.93.32.01.40.90.70.91.20.7
Other current assets6.52.71.12.02.72.71.80.90.70.7
Current assets1207437163132135.97.634
Property, plant and equipment3.21.81.41.41.31.40.70.91.31.1
Right-of-use (leased) assets0.91.00.10.30.60.90.90——
Total assets1247739183335146.88.935
Accounts payable2.71.01.02.00.61.84.57.73.80.6
Current liabilities116.116156.01016r187.836
Lease liabilities (non-current)0.80.90—0.20.50.20——
Total liabilities127.82324211321228.237
Retained earnings−529−532−505−457−421−395−371−344−325−279
Shareholders' equity1116916−5.91222−6.4−150.7−1.5
Total liabilities and equity1247739183335146.88.935
Shares outstanding35332310r7.96.00.10.0r0.2r0.0r
Cash-flow statement
Share-based compensation249.88.27.9——————
Cash from operating activities23−19−31−25−23−23−24r−15−15−14
Capital expenditure−1.5−0.6−0.1−0.2−0.1−0.8−0.0−0.1−0.5−0.3
Cash from investing activities−27−1.0−20−0.2−0.1−0.8−0.0−0.1−0.5−1.3
Debt issued————1503.70——
Debt repaid0−11−6.3−0.7——————
Shares issued0.50.30.102.5r0.2011——
Shares bought back−6.00————————
Cash from financing activities1539521021423013−11r7.4
Change in cash11200.9−15−1.8196.6r−1.7−26r−8.2
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Delcath Systems, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • HEPZATO KIT$79 M93%
  • CHEMOSAT$6 M7.5%

Countries and regions

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at Delcath Systems, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$5.8 M
Gerard Michel
Other top executives, average
$2.0 M
the CEO earned 2.8× this
$100 invested is now
$281
Delcath Systems, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Gerard Michel$5.8 M$3.1 M$2.0 M$281
2024Gerard Michel$2.2 M$4.9 M$1.0 M$334
2023Gerard Michel$2.5 M$2.2 M$1.1 M$116

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Delcath Systems, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling
  • Delisting noticeFiling
  • Delisting noticeFiling

Delisting notice 2 · Auditor changed 1 · Directors and officers 4 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 14

Delcath Systems, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Bylaws or fiscal year changed8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Bylaws or fiscal year changed8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Auditor changed8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Delisting notice8-K
Delisting noticeDirectors and officersShareholder vote8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of Delcath Systems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$7 MPrivate placement after listing$2 to $10 million17equity, optionsSEC
Mar 2023$25 MPrivate placement after listing$10 to $50 million17equity, optionsSEC
Dec 2022$4 MPrivate placement after listing$2 to $10 million7equity, optionsSEC
Jul 2022$5 MPrivate placement after listing$2 to $10 million6equity, optionsSEC
Aug 2019$10 MPrivate placement after listing$2 to $10 million33equity, optionsSEC
Jul 2019$20 MPrivate placement after listing$10 to $50 million31equity, optionsSEC
Jul 2018$2 MPrivate placement after listingUnder $2 million1debt, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by Delcath Systems, Inc.#

$140 K spent on lobbying the US Congress and federal agencies in 2026, most often on health issues.

Lobbying, 2026
$140 K
#1,091 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2026
2026 so far
$140 K
  • Health Issues3 reports

Lobbying firms hired in 2026

BGR Government Affairs $140 K

Delcath Systems, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$140 K—3

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Delcath Systems, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at Delcath Systems, Inc.#

1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $78 K a year.

Certified, FY2026
1
#1,903 among companies on value.today
Worker positions
1
Median wage offered
$78 K
a year, full-time
Applications filed
1
Delcath Systems, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Regulatory Affairs Associate, PublishingRegulatory Affairs Specialists1$78 K

Where: Chandler, AZ 1

Delcath Systems, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202611$78 K1
FY202511$83 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Delcath Systems, Inc.

FDA drug approvals: Delcath Systems, Inc.#

1 approved applications held; 1 approvals and 0 new uses in 2023.

Approvals held
1
New molecular entities
0
New uses approved
0
efficacy supplements
Generics
0
1 new drugs, 0 biologics
Delcath Systems, Inc.: latest FDA approvals
ApprovedDrugKind
2023-08-14HepzatoMelphalan Hydrochloride · NDA201848New drug (NDA)

Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (DELCATH SYSTEMS INC), so they follow acquisitions

Discuss Delcath Systems, Inc.#

2 automatic updates and 0 member comments. Sign in to comment and react.

  • Results announced on 9 November 2026automatic update · Nov 9, 2026

    Delcath Systems, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $35 million (up 71% from a year earlier) and net income of $7 million (up 737% from a year earlier).

  • Mutual funds: 99 funds hold $56 millionautomatic update · Jul 31, 2026

    99 mutual funds in 1 country hold shares of Delcath Systems, Inc. worth $56 million, about 9.7% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 44 funds added shares and 29 sold; on balance they bought $7 million. Share splits are not counted as trading.

How Delcath Systems, Inc. compares in Medical Devices

  • Market cap$500 M · higher than 50% of 142
  • Revenue$85 M · higher than 38% of 155
  • Net margin6.0% · higher than 64% of 144
  • Revenue growth129.1% · higher than 96% of 104
  • P/E ratio75.2× · lower than 11% of 47
  • Price / sales4.5× · lower than 33% of 96
  • Price / book4.5× · lower than 33% of 99
  • FCF yield4.2% · higher than 83% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Delcath Systems, Inc.🇺🇸$500 M75.2×6.0%+129.1%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 20, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of February 13, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikidata, SEC annual report, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Delcath Systems, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Delcath Systems, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Delcath Systems, Inc.? Suggest a correction